Potentially inappropriate medication use in older patients with breast and colorectal cancer.
Meghan S KaruturiHolly M HolmesXiudong LeiMichael JohnsonCarlos H BarcenasScott B CantorGary E GallickRobert C BastSharon H GiordanoPublished in: Cancer (2018)
These findings require further prospective confirmation, but they support a correlation between polypharmacy and adverse outcomes for cancer patients and call into question the association with PIMs. Cancer 2018;124:3000-7. © 2018 American Cancer Society.